# Katsunori Tatsugami

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/katsunori-tatsugami/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,162 |
| Field | Prostate Cancer Treatment and Research |
| h-index | 32 |
| i10-index | 95 |
| Last Known Institution | Kitakyushu Municipal Medical Center |
| OpenAlex ID | https://openalex.org/A5019215076 |
| Works | 259 |

## Researcher papers

- [Foxo3a Suppression of Urothelial Cancer Invasiveness through Twist1, Y-Box–Binding Protein 1, and E-Cadherin Regulation](https://scholariq.org/papers/foxo3a-suppression-of-urothelial-cancer-invasiveness-through-twist1-y-box/)
- [Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity](https://scholariq.org/papers/immune-suppression-by-pd-l2-against-spontaneous-and-treatment-related-antitumor/)
- [Evaluation of Narrow-Band Imaging as a Complementary Method for the Detection of Bladder Cancer](https://scholariq.org/papers/evaluation-of-narrow-band-imaging-as-a-complementary-method-for-the-detection-of/)
- [Peroxisome Proliferator-Activated Receptor γ Coactivator-1α Interacts with the Androgen Receptor (AR) and Promotes Prostate Cancer Cell Growth by Activating the AR](https://scholariq.org/papers/peroxisome-proliferator-activated-receptor-coactivator-1-interacts-with-the/)
- [Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines](https://scholariq.org/papers/inositol-1-4-5-trisphosphate-ip3-receptor-type1-ip3r1-modulates-the-acquisition/)
- [Androgen Receptor Signaling Regulates Cell Growth and Vulnerability to Doxorubicin in Bladder Cancer](https://scholariq.org/papers/androgen-receptor-signaling-regulates-cell-growth-and-vulnerability-to/)
- [Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase Inhibitor](https://scholariq.org/papers/suppressed-recurrent-bladder-cancer-after-androgen-suppression-with-androgen/)
- [Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7](https://scholariq.org/papers/potential-role-for-yb-1-in-castration-resistant-prostate-cancer-and-resistance/)
- [Immunotherapy for Renal Cell Carcinoma](https://scholariq.org/papers/immunotherapy-for-renal-cell-carcinoma/)
- [Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin](https://scholariq.org/papers/foxo3a-expression-and-acetylation-regulate-cancer-cell-growth-and-sensitivity-to/)
- [Assessment of surgical skills by using surgical navigation in robot-assisted partial nephrectomy](https://scholariq.org/papers/assessment-of-surgical-skills-by-using-surgical-navigation-in-robot-assisted/)

## Researcher topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)

## Researcher university

- [Kitakyushu Municipal Medical Center](https://scholariq.org/institutions/kitakyushu-municipal-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.